These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36655240)

  • 1. [Value of glycosylated hemoglobin A1c and apolipoprotein A-1 ratio on predicting outcome of patients with acute coronary syndrome].
    Wang YJ; Mu HN; Yang RY; Zhang WD; Wang XY; Wang SM; Ji FS; Dong J; Yu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):38-44. PubMed ID: 36655240
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome.
    Song F; Zhou Y; Zhang K; Liang YF; He X; Li L
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):570-578. PubMed ID: 33358616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
    Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
    Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
    Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
    Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao N; Mi L; Liu X; Pan S; Xu J; Xia D; Liu Z; Zhang Y; Xiang Y; Yuan Z; Guan G; Wang J
    PLoS One; 2015; 10(10):e0140532. PubMed ID: 26468876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
    Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
    BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes mellitus and hemoglobin A1c level on outcomes among Chinese patients with acute coronary syndrome.
    Xiong R; He L; Du X; Dong JZ; Ma CS
    Clin Cardiol; 2020 Jul; 43(7):723-731. PubMed ID: 32427378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome.
    Xu S; Zhou B; Zhou B; Zheng J; Xu Q; Wang B; Fu M; Meng Y
    Comput Math Methods Med; 2022; 2022():7796809. PubMed ID: 35912151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention.
    Xu T; Zhan Y; Lu N; He Z; Su X; Tan X
    BMC Cardiovasc Disord; 2017 Dec; 17(1):284. PubMed ID: 29197333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of Advanced Lung Cancer Inflammation Index in Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao G; Tang W; Yang C; Liu X; Huang J
    Int Heart J; 2024 Jul; 65(4):621-629. PubMed ID: 39010222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of glycated hemoglobin in acute coronary syndrome patients from the CCC-ACS project : Findings from a multicenter retrospective observational study.
    Zhao X; Kang Y; Wang X; Yang X; Ai G; Liu Y; Xu P; Zhang J; Gu C; Zhang Y; Hao Y; Zhao D; Han Y;
    Herz; 2021 Sep; 46(Suppl 2):287-294. PubMed ID: 33231709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
    Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
    J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study.
    Kosaki R; Minoura Y; Ogura K; Oishi Y; Tanaka L; Arai K; Nomura K; Sakai K; Sekimoto T; Nisikura T; Tsujita H; Kondo S; Tsukamoto S; Hamazaki Y; Kobayashi Y
    J Cardiol; 2018 Dec; 72(6):494-500. PubMed ID: 29887328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between neutrophil/lymphocyte ratio combined with low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with acute coronary syndrome].
    Yuan S; Pu T; Wang Z; Li L; Gao P; Zhang L; Ma Y; Qi Q; Fan X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Mar; 34(3):274-279. PubMed ID: 35574745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function as predictor in patients with coronary syndrome treated by percutaneous coronary intervention.
    Cheng X; He Y; Fan H; Liu T; Pan W; Wang K; Jin J
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study.
    Yang Y; Xu Y; Wang J; Zhai X; Jiang H
    BMC Cardiovasc Disord; 2020 Nov; 20(1):500. PubMed ID: 33256605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of the glycated hemoglobin levels and prognostic nutritional index as a prognostic marker in patients with acute coronary syndrome and type 2 diabetes mellitus.
    Sun S; Wang Y; Pang S; Wu X
    Lipids Health Dis; 2024 Jan; 23(1):12. PubMed ID: 38212760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of D-dimer level and neutrophil to lymphocyte ratio predicts long-term clinical outcomes in acute coronary syndrome after percutaneous coronary intervention.
    Gu LF; Gu J; Wang SB; Wang H; Wang YX; Xue Y; Wei TW; Sun JT; Lian XQ; Liu JB; Jia EZ; Wang LS
    Cardiol J; 2023; 30(4):576-586. PubMed ID: 34490603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.